Table 1.
Author | Geographic area | Sample size | Etiology | Study design | Survival in surveillance group | Survival in control group |
---|---|---|---|---|---|---|
Zhang et al. [78] | Asia | Screening 9373 Control 9443 | HBV | RCT | 5-yr survival 46.4% | 5-yr survival 0% |
Yuen et al. [79] | Asia | Screening 142 Control 164 | HBV | CC | Significantly higher survival than control | |
Tong et al. [81] | United States | Screening 26 Control 52 | HBV | CC | 5-yr survival 35.7% | 5-yr survival 16.3% |
Yang et al. [84] | United States | Screening 136 Control 307 | HCV Alcohol | CC | Significantly higher survival than control | |
Trevisani et al. [85] | Europe | Screening 158 Symptomatic 67 | HCV HBV | CC | Median survival 24 months | Median survival 7 months |
Ando et al. [86] | Asia | Screening 91 Symptomatic 181 | HCV | CC | 5-yr survival 52% | 5-yr survival 23% |
CC=case-control.